Literature DB >> 20093403

Cellular barcoding tool for clonal analysis in the hematopoietic system.

Alice Gerrits1, Brad Dykstra, Olga J Kalmykowa, Karin Klauke, Evgenia Verovskaya, Mathilde J C Broekhuis, Gerald de Haan, Leonid V Bystrykh.   

Abstract

Clonal analysis is important for many areas of hematopoietic stem cell research, including in vitro cell expansion, gene therapy, and cancer progression and treatment. A common approach to measure clonality of retrovirally transduced cells is to perform integration site analysis using Southern blotting or polymerase chain reaction-based methods. Although these methods are useful in principle, they generally provide a low-resolution, biased, and incomplete assessment of clonality. To overcome those limitations, we labeled retroviral vectors with random sequence tags or "barcodes." On integration, each vector introduces a unique, identifiable, and heritable mark into the host cell genome, allowing the clonal progeny of each cell to be tracked over time. By coupling the barcoding method to a sequencing-based detection system, we could identify major and minor clones in 2 distinct cell culture systems in vitro and in a long-term transplantation setting. In addition, we demonstrate how clonal analysis can be complemented with transgene expression and integration site analysis. This cellular barcoding tool permits a simple, sensitive assessment of clonality and holds great promise for future gene therapy protocols in humans, and any other applications when clonal tracking is important.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093403     DOI: 10.1182/blood-2009-06-229757

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  86 in total

1.  Counting stem cells: methodological constraints.

Authors:  Leonid V Bystrykh; Evgenia Verovskaya; Erik Zwart; Mathilde Broekhuis; Gerald de Haan
Journal:  Nat Methods       Date:  2012-05-30       Impact factor: 28.547

2.  High-throughput, sensitive quantification of repopulating hematopoietic stem cell clones.

Authors:  Sanggu Kim; Namshin Kim; Angela P Presson; Dong Sung An; Si Hua Mao; Aylin C Bonifacino; Robert E Donahue; Samson A Chow; Irvin S Y Chen
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.

Authors:  Martijn H Brugman; Anna-Sophia Wiekmeijer; Marja van Eggermond; Ingrid Wolvers-Tettero; Anton W Langerak; Edwin F E de Haas; Leonid V Bystrykh; Jon J van Rood; Gerald de Haan; Willem E Fibbe; Frank J T Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

4.  Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants.

Authors:  Samson J Koelle; Diego A Espinoza; Chuanfeng Wu; Jason Xu; Rong Lu; Brian Li; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 5.  Molecular neuroanatomy: a generation of progress.

Authors:  Jonathan D Pollock; Da-Yu Wu; John S Satterlee
Journal:  Trends Neurosci       Date:  2013-12-31       Impact factor: 13.837

Review 6.  Clonal interrogation of stem cells.

Authors:  Kristin Hope; Mickie Bhatia
Journal:  Nat Methods       Date:  2011-04       Impact factor: 28.547

Review 7.  Differentiation-based model of hematopoietic stem cell functions and lineage pathways.

Authors:  Thomas Höfer; Hans-Reimer Rodewald
Journal:  Blood       Date:  2018-07-24       Impact factor: 22.113

8.  Clonal-level lineage commitment pathways of hematopoietic stem cells in vivo.

Authors:  Rong Lu; Agnieszka Czechowicz; Jun Seita; Du Jiang; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

Review 9.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

10.  Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.

Authors:  Christian Brendel; Walther Hänseler; Vital Wohlgensinger; Matteo Bianchi; Serap Tokmak; Linping Chen-Wichmann; Elena Kuzmenko; Nikola Cesarovic; Flora Nicholls; Janine Reichenbach; Reinhard Seger; Manuel Grez; Ulrich Siler
Journal:  Hum Gene Ther Methods       Date:  2013-05-02       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.